Advertisement

Topics

ConjuChem Biotechnologies Inc. Company Profile

15:10 EST 22nd November 2017 | BioPortfolio


News Articles [86 Associated News Articles listed on BioPortfolio]

DGAP-HV: Elanix Biotechnologies AG: -3-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -2-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -5-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -6-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -4-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

Fujifilm Diosynth Biotechnologies opens new UK lab

Fujifilm Diosynth Biotechnologies has opened a $9m process development laboratory in Teeside, UK.

Lion Biotechnologies changes name to Iovance Biotherapeutics

Iovance Biotherapeutics, a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, changed its corporate name from Lion Biotechnologies t...

Adaptive Biotechnologies kündigt Kooperation mit Amgen für den Fortschritt der klinischen Entwicklung des clonoSEQ-Assays bei Multiplem Myelom an

Adaptive Biotechnologies, eines der führenden Unternehmen für die Kombination von Sequenzierung der nächsten Generation (Next-Generation Sequencing, NGS) und durchdachter Bioinformatik für die Pro...

Drugs and Medications [0 Results]

None

PubMed Articles [13 Associated PubMed Articles listed on BioPortfolio]

Ethical principles for the use of human cellular biotechnologies.

Is De-extinction Special?

I have been involved with the current interest in de-extinction since early 2012, nearly its beginning. I have given a lot of thought to the potential risks and benefits of de-extinction. But only rec...

Overcoming the energetic limitations of syngas fermentation.

The fermentation of synthesis gas (including carbon monoxide, carbon dioxide, and hydrogen) with anaerobic acetogens is an established biotechnological process that has recently been transferred to a ...

'You are inferior!' Revisiting the expressivist argument.

According to the expressivist argument the choice to use biotechnologies to prevent the birth of individuals with specific disabilities is an expression of disvalue for existing people with this disab...

Electricity production and microbial characterization of thermophilic microbial fuel cells.

Thermophilic microbial fuel cell (TMFC) offers many benefits, but the investigations on the diversity of exoelectrogenic bacteria are scarce. In this study, a two-chamber TMFC was constructed using et...

Clinical Trials [0 Results]

None

Companies [105 Associated Companies listed on BioPortfolio]

ConjuChem Biotechnologies Inc.

ConjuChem, LLC

ConjuChem creates novel, next-generation medicines using unique, long-acting therapeutic peptides. Underlying all ConjuChem compounds are bioconjugation platforms called Drug Affi...

ConjuChem

ConjuChem: The Next Generation in MedicinesConjuChem creates novel, next-generation medicines using unique, long-acting therapeutic peptides. Underlying all ConjuChem compounds are bioconjugation plat...

ConjuChem Incorporated

ConjuChem Inc. is a biotechnology company that has developed proprietary technology that enable the rapid creation of improved patentable new drugs from existing drugs.The new drugs will have similar ...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

More Information about "ConjuChem Biotechnologies Inc." on BioPortfolio

We have published hundreds of ConjuChem Biotechnologies Inc. news stories on BioPortfolio along with dozens of ConjuChem Biotechnologies Inc. Clinical Trials and PubMed Articles about ConjuChem Biotechnologies Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ConjuChem Biotechnologies Inc. Companies in our database. You can also find out about relevant ConjuChem Biotechnologies Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record